MAIN MENU
QUICK LINKS
CONNECT WITH US

Button
Coronavirus (COVID-19) updates, visitor restrictions and resources →

CSF analysis

  • Definition
    • Cerebrospinal fluid (CSF) analysis is a group of laboratory tests that measure chemicals in the fluid that surrounds and protects the brain and spinal cord. The tests may look for proteins, sugar (glucose), and other substances.

  • Alternative Names
    • Cerebrospinal fluid analysis

  • How the Test is Performed
    • A sample of CSF is needed. A lumbar puncture, also called a spinal tap, is the most common way to collect this sample. Less common ways to take a fluid sample include:

      After the sample is taken, it is sent to the laboratory for evaluation.

  • How to Prepare for the Test
    • Your health care provider will tell you how to prepare for lumbar puncture.

  • Why the Test is Performed
  • Normal Results
    • Normal results include:

      • Antibodies and DNA of common viruses: None
      • Bacteria: No bacteria grows in a lab culture
      • Cancerous cells: No cancerous cells present
      • Cell count: less than 5 white blood cells (all mononuclear) and 0 red blood cells
      • Chloride: 110 to 125 mEq/L
      • Fungus: None
      • Glucose: 50 to 80 mg/dL(or greater than two-thirds of blood sugar level)
      • Glutamine: 6 to 15 mg/dL
      • Lactate dehydrogenase: less than 2.0 to 7.2 U/mL
      • Oligoclonal bands: 0 or 1 bands that are not present in a matched serum sample
      • Protein: 15 to 60 mg/dL

      Normal value ranges may vary slightly among different laboratories. Talk to your doctor about the meaning of your specific test results.

      The examples above show the common measurements for results for these tests. Some laboratories use different measurements or may test different specimens.

      Note: mg/dL = milligrams per deciliter

  • What Abnormal Results Mean
    • An abnormal CSF analysis result may be due to many different causes, including:

  • References
    • Griggs RC, Jozefowicz RF, Aminoff MJ. Approach to the patient with neurologic disease. In: Goldman L, Schafer AI, eds. Goldman's Cecil Medicine. 25th ed. Philadelphia, PA: Elsevier Saunders; 2016:chap 396.

      Martorana A, Sancesario GM, Esposito Z, et al. Plasmin system of Alzheimer's disease: CSF Analysis. J Neural Transm. 2012:119:763-769. PMID: 22415062. www.ncbi.nlm.nih.gov/pubmed/22415062.

      Rosenberg GA. Brain edema and disorders of cerebrospinal fluid circulation. In: Daroff RB, Fenichel GM, Jankovic J, Mazziotta JC, eds. Bradley's Neurology in Clinical Practice. 6th ed. Philadelphia, PA: Elsevier Saunders; 2012:chap 59.